HOLUBIAK MYRON Z 4
Accession 0001213900-24-096888
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:00 PM ET
Size
27.3 KB
Accession
0001213900-24-096888
Insider Transaction Report
- Award
Stock Option (Right to Purchase Common Stock)
2024-11-07+350,000→ 350,000 totalExercise: $0.38Exp: 2034-11-07→ Common Stock (350,000 underlying) - Award
Stock Option (Right to Buy)
2024-11-07+75,000→ 75,000 total(indirect: See footnote)Exercise: $0.38Exp: 2034-11-07→ Common Stock (75,000 underlying)
- 129,450
Warrant to Purchase Common Stock
Exercise: $1.42Exp: 2025-04-05→ Common Stock (129,450 underlying) - 784,314
Warrant to Purchase Common Stock
Exercise: $1.15Exp: 2025-08-14→ Common Stock (784,314 underlying) - 40,000
Stock Option (Right to Purchase Common Stock)
Exercise: $3.45Exp: 2027-09-13→ Common Stock (40,000 underlying) - 150,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.62Exp: 2028-09-04→ Common Stock (150,000 underlying) - 1,992,243
Common Stock
- 400,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.25Exp: 2032-10-04→ Common Stock (400,000 underlying) - 10,000(indirect: See footnote)
Stock Option (Right to Purchase Common Stock)
Exercise: $2.00Exp: 2031-07-22→ Common Stock (10,000 underlying) - 26,667
Stock Option (Right to Purchase Common Stock)
Exercise: $8.10Exp: 2025-10-01→ Common Stock (26,667 underlying) - 558,597
Warrant to Purchase Common Stock
Exercise: $0.77Exp: 2025-09-27→ Common Stock (558,597 underlying) - 400,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.70Exp: 2033-10-10→ Common Stock (400,000 underlying) - 650,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (650,000 underlying) - 15,000(indirect: See footnote)
Stock Option (Right to Purchase Common Stock)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (15,000 underlying) - 300,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.00Exp: 2031-07-22→ Common Stock (300,000 underlying) - 200,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.01Exp: 2030-10-06→ Common Stock (200,000 underlying) - 175,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.67Exp: 2029-10-08→ Common Stock (175,000 underlying)
Footnotes (6)
- [F1]The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F2]The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
- [F3]The warrant is fully vested and exercisable immediately.
- [F4]The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F5]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F6]The options are vested in full and exercisable immediately.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Related Parties
1- filerCIK 0001199080
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 5:00 PM ET
- Size
- 27.3 KB